A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice is a research paper published in Journal of Clinical Investigation (2022). On theSindex it has a DataRank of 0. It has been cited 35 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH NIAID
Grant: R01AI117321
NIH NIAID
Grant: R01AI146329
X-Vax, Technologies
Grant: NA
NIH NIAID
Grant: P30 AI124414
National Institutes of Health
Grant: 2P30AI124414-07
ERC Einstein-Rockefeller-CUNY Center for AIDS research
National Institutes of Health
Grant: 5R01AI146329-02
Characteristics and protective efficacy of human antibodies against M. tuberculosis
National Institutes of Health
Grant: 6R01AI117321-04
Attenuated HSV Vaccines That Induce Protective Mucosal Antibodies
National Institutes of Health
Grant: 2R01AI134367-07A1
Mechanisms Underlying the HIV-HSV-2 Syndemic
FWCI
3.65
Citation Percentile
0.9%
Influential Citations
2
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals